Patients with non-alcoholic fatty liver disease may actually benefit from GLP-1 receptor agonists, as clinical studies show these medications can reduce liver fat content and improve liver enzyme levels
For those on GLP-1 medications like Ozempic, Wegovy, or Mounjaro, this becomes even more critical
And thats the kind of danger zone that the female athlete triad is all about: when chronic energy deficiency becomes too much and suppresses reproductive function and suppresses the formation of bone. That leads to low estrogen levels too
A patient information form
Novo Nordisk, el fabricante de los exitosos medicamentos para bajar de peso y tratar la diabetes Wegovy y Ozempic, ha firmado un acuerdo con Ascendis Pharma, con sede en Dinamarca, para aprovechar la avanzada tecnologa de administracin de medicamentos de esta ltima.